The following is a summary of “Novel protein C variant p.C101F results in early intracellular degradation that drives type I ...
PALO ALTO, CALIFORNIA / ACCESS Newswire / February 26, 2025 / Bioz, Inc. , the premier provider of AI-powered citation ...
Vincent, an Australian-founded skincare and supplement company developing world-class products that promote health and well-being, with more than 1.1 million units sold, is launching into the U.S.
Paradox Immunotherapeutics ("Paradox"), a pharmaceutical company focused on the development of innovative antibody therapies that treat protein misfolding diseases, today announced a $10 million ...
E1s and E2s first work generically across the cell to activate and prepare ubiquitin for attachment. E3 ligases then ensure that the tag is added to the right protein; as such, hundreds of specific ...
Researchers at Shanghai Huashan Hospital have identified a novel therapeutic target that could lead to the world's first ...
A man who should have developed early-onset Alzheimer's disease due to a genetic mutation is still symptom-free in his 70s.
The factor that tips you over the edge from being at risk for a disease to actually developing the disease is not always ...
A research collaboration has found that besides regulating the fusion of mitochondria, Mitofusin 2 also ensures protein quality control. This discovery could open up new routes to treating ...
A new study reveals that Mitofusin 2 (MFN2) plays a crucial role in protein quality control, preventing harmful protein ...
Researchers from Cologne, Bochum, Padova and Angers have discovered a novel connection between mitochondrial function, protein quality control and cellular health, whose failure could be the leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results